Home › Funds › PFM Health Sciences, LP › CYTK

PFM Health Sciences, LP position in CYTK

CYTOKINETICS INC COM NEW · Health Care

PFM Health Sciences, LP reported holding 191,686 shares of CYTK (CYTOKINETICS INC COM NEW) in its Q2 2026 13F filing — a position valued at US$16.3M, representing 1.43% of its reported portfolio and ranking #21 among its reported holdings. PFM Health Sciences, LP has disclosed CYTK holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)191.69K sh
Reported value held$16.33M
Portfolio Weight1.43%
First reportedQ3 2023
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's CYTK position evolved

PFM Health Sciences, LP first disclosed a stake in CYTK in Q3 2023 at 25,000,000 shares (US$21.3M). The position peaked in Q2 2024 at 1,757,192 shares, worth US$95.2M. Across 6 filings, PFM Health Sciences, LP increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 191,686 shares valued at US$16.3M. Notable position changes include a 68% trim in Q4 2023 (shares fell 16% over the following quarter), a 76% trim in Q2 2024 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 25.00M $21.33M New
Q4 2023 8.00M $14.09M Reduce
Q1 2024 7.20M $11.45M Reduce
Q2 2024 1.76M $95.20M Reduce
Q3 2024 1.76M $92.78M Hold
Q2 2026 191.69K $16.33M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC COM NEW) is a Health Care company. 52 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has PFM Health Sciences, LP held CYTK?

PFM Health Sciences, LP has disclosed CYTK holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

What is PFM Health Sciences, LP's current position in CYTK?

As of Q2 2026, PFM Health Sciences, LP holds 191.69K shares of CYTK (CYTOKINETICS INC COM NEW), valued at $16.33M, representing 1.43% of its reported portfolio and ranking #21.

Has PFM Health Sciences, LP been buying or selling CYTK?

In the latest 13F filing (Q2 2026), PFM Health Sciences, LP newly opened its position in CYTK. The position peaked in Q2 2024 at 1.76M shares.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.